US 7351691
Glycopeptide phosphonate derivatives
granted A61KA61K38/14A61K47/06
Quick answer
US patent 7351691 (Glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/14, A61K47/06, A61K47/12, A61K47/26